May. 11 at 1:46 PM
$SLDB As of May 2026, Solid Biosciences (SLDB) has a moderate short interest of 9.78% of the public float, with ~9.4 million shares sold short. A short squeeze risk increases if the stock breaks above its 52-week high of
$8.87, potentially triggering a rapid upward movement toward analyst targets of
$12–
$26.
KEY Short Squeeze Factors
(May 2026):Short Interest: 9.44 million shares (9.78% of float).Days to Cover: 9.4, indicating it would take nearly 10 days to cover all short positions.Price Level: The stock recently traded around
$7.27, with a 52-week high of
$8.87.
ANALYST Outlook: The average price target is over 130% higher than the current price (around
$17), which may create pressure on shorts if positive clinical data or news drives the price up.
A significant surge above the
$8.87 resistance level could force short sellers to cover, especially given the high percentage of bullish, high-target analyst coverage
